These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 34044094)
1. ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response. Chen G; Zhao Q; Yuan B; Wang B; Zhang Y; Li Z; Du S; Zeng Z Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):491-501. PubMed ID: 34044094 [TBL] [Abstract][Full Text] [Related]
2. METTL3-Mediated STING Upregulation and Activation in Kupffer Cells Contribute to Radiation-Induced Liver Disease via Pyroptosis. Wang B; Zhang Y; Niu H; Zhao X; Chen G; Zhao Q; Ma G; Du S; Zeng Z Int J Radiat Oncol Biol Phys; 2024 May; 119(1):219-233. PubMed ID: 37914138 [TBL] [Abstract][Full Text] [Related]
3. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928 [TBL] [Abstract][Full Text] [Related]
4. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767 [TBL] [Abstract][Full Text] [Related]
5. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239 [TBL] [Abstract][Full Text] [Related]
6. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. Yang Z; Cai Z; Yang C; Luo Z; Bao X EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460 [TBL] [Abstract][Full Text] [Related]
7. KDM4C represses liver fibrosis by regulating H3K9me3 methylation of ALKBH5 and m6A methylation of snail1 mRNA. Zhou HY; Wang BQ; Chen MX; Wang YF; Jiang YF; Ma J J Dig Dis; 2024 May; 25(5):298-309. PubMed ID: 38938016 [TBL] [Abstract][Full Text] [Related]
8. Decreased Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942 [TBL] [Abstract][Full Text] [Related]
9. m6A mRNA methylation-mediated MAPK signaling modulates the nasal mucosa inflammatory response in allergic rhinitis. Wang R; Liang J; Wang Q; Zhang Y; Lu Y; Zhan X; Wang S; Gu Q Front Immunol; 2024; 15():1344995. PubMed ID: 39011034 [TBL] [Abstract][Full Text] [Related]
10. ALKBH5 activates FAK signaling through m6A demethylation in Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222 [No Abstract] [Full Text] [Related]
11. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability. Feng L; Fan Y; Zhou J; Li S; Zhang X FEBS Lett; 2021 Aug; 595(15):2007-2014. PubMed ID: 34105773 [TBL] [Abstract][Full Text] [Related]
12. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551 [TBL] [Abstract][Full Text] [Related]
13. ALKBH5-mediated m Chen Y; Zhou P; Deng Y; Cai X; Sun M; Sun Y; Wu D Clin Transl Med; 2023 Feb; 13(2):e1198. PubMed ID: 36792369 [TBL] [Abstract][Full Text] [Related]
14. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. Yang K; Zhao Y; Hu J; Gao R; Shi J; Wei X; Chen J; Hu K; Sun A; Ge J J Adv Res; 2024 Jul; 61():193-209. PubMed ID: 37689242 [TBL] [Abstract][Full Text] [Related]
15. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126 [TBL] [Abstract][Full Text] [Related]
16. m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. Liu X; Feng M; Hao X; Gao Z; Wu Z; Wang Y; Du L; Wang C Oncogene; 2023 Jun; 42(25):2047-2060. PubMed ID: 37149664 [TBL] [Abstract][Full Text] [Related]
17. USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma. Fu D; Si Q; Yu C; Han Z; Zang L Mol Carcinog; 2023 Nov; 62(11):1700-1716. PubMed ID: 37493109 [TBL] [Abstract][Full Text] [Related]
18. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518 [TBL] [Abstract][Full Text] [Related]
19. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Shao Y; Liu Z; Song X; Sun R; Zhou Y; Zhang D; Sun H; Huang J; Wu C; Gu W; Zheng X; Jiang J Clin Transl Med; 2023 Jul; 13(7):e1318. PubMed ID: 37381158 [TBL] [Abstract][Full Text] [Related]
20. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]